Cargando…
A systematic literature review informing the consensus statement on efficacy and safety of pharmacological treatment with interleukin-6 pathway inhibition with biological DMARDs in immune-mediated inflammatory diseases
OBJECTIVES: Informing an international task force updating the consensus statement on efficacy and safety of biological disease-modifying antirheumatic drugs (bDMARDs) selectively targeting interleukin-6 (IL-6) pathway in the context of immune-mediated inflammatory diseases. METHODS: A systematic li...
Autores principales: | Kastrati, Kastriot, Aletaha, Daniel, Burmester, Gerd R, Chwala, Eva, Dejaco, Christian, Dougados, Maxime, McInnes, Iain B, Ravelli, Angelo, Sattar, Naveed, Stamm, Tanja A, Takeuchi, Tsutomu, Trauner, Michael, van der Heijde, Desirée, Voshaar, Marieke J H, Winthrop, Kevin, Smolen, Josef S, Kerschbaumer, Andreas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9462104/ https://www.ncbi.nlm.nih.gov/pubmed/36260501 http://dx.doi.org/10.1136/rmdopen-2022-002359 |
Ejemplares similares
-
Points to consider for the treatment of immune-mediated inflammatory diseases with Janus kinase inhibitors: a systematic literature research
por: Kerschbaumer, Andreas, et al.
Publicado: (2020) -
Automated evaluation of ANA under real-life conditions
por: Loock, Clemens Dario, et al.
Publicado: (2017) -
Points to consider for the treatment of immune-mediated inflammatory diseases with Janus kinase inhibitors: a consensus statement
por: Nash, Peter, et al.
Publicado: (2021) -
Efficacy, immunogenicity and safety of vaccination in adult patients with autoimmune inflammatory rheumatic diseases: a systematic literature review for the 2019 update of EULAR recommendations
por: Rondaan, Christien, et al.
Publicado: (2019) -
Antiphospholipid syndrome: state of the art on clinical practice guidelines
por: Limper, Marteen, et al.
Publicado: (2018)